CIK 0001661998
- Non-accelerated filer
- Smaller reporting company
Q32 Bio Inc.
Sign in to watch- Ticker
- QTTB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473468154
- Phone
- +1 781-999-0232
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Former names
- Q32 Bio Inc., Homology Medicines, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $320,396
- in 6 filings
Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-30 | Flynn James E 10% owner | Sale | −509,970 | $15.45 | $7.9M | 0 |
| 2020-01-29 | Flynn James E 10% owner | Sale | −8,857 | $15.45 | $137K | 509,970 |
| 2020-01-28 | Flynn James E 10% owner | Sale | −65,891 | $15.51 | $1.0M | 518,827 |
| 2020-01-27 | Flynn James E 10% owner | Sale | −193,359 | $15.77 | $3.0M | 584,718 |
| 2020-01-24 | Flynn James E 10% owner | Sale | −380,256 | $15.69 | $6.0M | 778,077 |
| 2020-01-02 | TZIANABOS ARTHUR President & CEO | Sale | −12,500 | $20.50 | $256K | 90,005 |
| 2020-01-02 | Seymour Albert Chief Scientific Officer | Sale | −9,133 | $20.50 | $187K | 154,017 |
| 2020-01-02 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion | +6,000 | $0.63 | $4K | 6,000 |
| 2020-01-02 | Smith W Bradford CFO, Treasurer & Secretary | Sale | −6,000 | $20.50 | $123K | 0 |
| 2020-01-02 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion · Employee Stock Option | −6,000 | 115,404 | ||
| 2019-12-24 | Flynn James E 10% owner | Sale | −198,767 | $21.95 | $4.4M | 2,321,199 |
| 2019-12-24 | Flynn James E 10% owner | Sale | −151,233 | $21.95 | $3.3M | 1,766,106 |
| 2019-12-23 | Flynn James E 10% owner | Sale | −74,384 | $21.83 | $1.6M | 2,519,966 |
| 2019-12-23 | Flynn James E 10% owner | Sale | −56,595 | $21.83 | $1.2M | 1,917,339 |
| 2019-12-20 | Flynn James E 10% owner | Sale | −11,999 | $21.50 | $258K | 2,594,350 |
| 2019-12-20 | Flynn James E 10% owner | Sale | −9,130 | $21.50 | $196K | 1,973,934 |
| 2019-12-19 | Flynn James E 10% owner | Sale | −7,168 | $21.68 | $155K | 2,606,349 |
| 2019-12-19 | Flynn James E 10% owner | Sale | −5,454 | $21.68 | $118K | 1,983,064 |
| 2019-12-11 | TZIANABOS ARTHUR President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +358,000 | 358,000 | ||
| 2019-12-11 | Cohn Gabriel Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +15,000 | 15,000 |
Page 18 of 25 · 492 trades